George is a Managing Director at Princeton Biopharma Capital Partners, LLC, with strong experience in the pharmaceutical industry and in private equity.  George is currently the Chief Financial Officer of Kaleo, Inc.

Prior to co-founding Princeton Biopharma Capital Partners, LLC, George was Chief Financial Officer of Aton Pharma, Inc., a specialty pharmaceutical company with products that treated orphan conditions and ophthalmology. He provided financial leadership to Aton through two acquisitions, a $30MM credit facility entered into in the difficult credit environment of 2009, and the sale of Aton to Valeant Pharmaceuticals in the spring of 2010.

Prior to joining Aton, George was an operating executive with Cerberus Operations and Advisory Company, leading diligence efforts and assuming key operating roles within portfolio companies. During his tenure with Cerberus, his positions included Chief Financial Officer of Velocita Wireless, where he led the complex standalone transition of this Cingular Wireless carve-out and spearheaded the eventual successful sale to Sprint. Prior to his time at Cerberus, he was the Senior VP of Finance for CAI Wireless Systems, a publicly-held wireless telecommunication services provider, where he offered financial leadership to the organization through several business plan changes, a financial restructuring through Chapter 11 of the US Bankruptcy Code, and the successful sale of the company. Prior to CAI, George was the Chief Financial Officer of CellularVision, a pioneer in the development of wireless telecommunication services, where he led the company’s successful initial public stock offering. He also held the position of Staff Vice President of Accounting at TriCon Leasing Corporation (a former subsidiary of Verizon) and has held several progressing positions with Ernst & Young. George holds a BS in Accounting from Seton Hall University and is a CPA.